ORYZON Presents Preliminary Data From Ongoing Phase Ib FRIDA Trial with Iadademstat Plus Gilteritinib in Relapsed/Refractory FLT3-mut AML Patients at EHA-2024
GlobeNewswire
· *Data from the first two cohorts demonstrated that combination of iadademstat plus gilteritinib was safe and showed strong..